---
title: "NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295793397.md"
description: "In Vancouver, British Columbia on August 13, 2026, NervGen, a company listed on NASDAQ under the ticker NGEN, shared its financial performance for the quarter concluding on June 30, 2026. The company, a leading late-stage clinical biopharmaceutical firm specializing in innovative neuroreparative treatments for spinal cord injury (SCI) and various neurotraumatic and neurologic ailments, also disclosed recent developments in their business operations."
datetime: "2026-08-13T11:33:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295793397.md)
  - [en](https://longbridge.com/en/news/295793397.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295793397.md)
generator: "portal-rs"
---

# NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

In Vancouver, British Columbia on August 13, 2026, NervGen, a company listed on NASDAQ under the ticker NGEN, shared its financial performance for the quarter concluding on June 30, 2026. The company, a leading late-stage clinical biopharmaceutical firm specializing in innovative neuroreparative treatments for spinal cord injury (SCI) and various neurotraumatic and neurologic ailments, also disclosed recent developments in their business operations.

### Related Stocks

- [NGEN.US](https://longbridge.com/en/quote/NGEN.US.md)

## Related News & Research

- [06:00 ETNovaGo Therapeutics cierra una ronda de financiación para un estudio en lesiones agudas de la médula espinal](https://longbridge.com/en/news/297765618.md)
- [Matricelf says FDA backs key design elements for first-in-human NewRal spinal cord injury trial](https://longbridge.com/en/news/297917329.md)
- [Coya Therapeutics posts September 2026 investor presentation on neurodegeneration pipeline](https://longbridge.com/en/news/297669200.md)
- [Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting | IRON Stock News](https://longbridge.com/en/news/297566501.md)
- [Zenas Biopharma outlines autoimmune disease pipeline in corporate presentation](https://longbridge.com/en/news/297813603.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**